These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16360361)

  • 1. Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries.
    Palazzuoli A; Gennari L; Calabria P; Quatrini I; Vecchiato L; De Paola V; Campagna MS; Palazzuoli V; Nuti R
    Am J Cardiol; 2005 Dec; 96(12):1705-10. PubMed ID: 16360361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function.
    Palazzuoli A; Maisel A; Caputo M; Fineschi M; Quatrini I; Calabrò A; Campagna MS; Franci B; Grothgar S; Pierli C; Nuti R
    Regul Pept; 2011 Feb; 167(1):129-33. PubMed ID: 21237213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
    Palazzuoli A; Caputo M; Fineschi M; Navarri R; Calabrò A; Cameli M; Campagna MS; Franci B; Pierli C; Nuti R; Maisel A
    Eur J Prev Cardiol; 2012 Jun; 19(3):366-73. PubMed ID: 21464097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction.
    Sadanandan S; Cannon CP; Chekuri K; Murphy SA; Dibattiste PM; Morrow DA; de Lemos JA; Braunwald E; Gibson CM
    J Am Coll Cardiol; 2004 Aug; 44(3):564-8. PubMed ID: 15358021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function.
    Palazzuoli A; Deckers J; Calabrò A; Campagna MS; Nuti R; Pastorelli M; Pasqui AL; Bruni F; Auteri A; Puccetti L
    Am J Cardiol; 2006 Nov; 98(10):1322-8. PubMed ID: 17134622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide levels predict extent and severity of coronary artery disease in non-ST elevation acute coronary syndrome and normal left ventricular function.
    Goyal BM; Sharma SM; Walia M
    Indian Heart J; 2014; 66(2):183-7. PubMed ID: 24814112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma brain natriuretic peptide levels in coronary heart disease with preserved systolic function.
    Palazzuoli A; Calabria P; Vecchiato L; Quatrini I; Carrera A; Bruni F; Puccetti L; Pastorelli M; Pasqui AL; Auteri A
    Clin Exp Med; 2004 Sep; 4(1):44-9. PubMed ID: 15598085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension.
    Palazzuoli A; Ascione R; Gallotta M; Calabrò A; Gonnelli S; Quatrini I; Campagna MS; Franci B; Nuti R
    Int J Cardiol; 2009 Nov; 137(3):295-8. PubMed ID: 18707771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between NT-pro BNP levels and early mitral annulus velocity (E') in patients with non-ST-segment elevation acute coronary syndrome.
    Barbosa MM; Nunes Mdo C; Castro LR; Nominato LF; Alencar MC; Ribeiro AL
    Echocardiography; 2008 Apr; 25(4):353-9. PubMed ID: 18177379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence and severity of coronary artery disease and changes in B-type natriuretic peptide levels in patients with a normal systolic function.
    Kim BS; Lee HJ; Shin HS; Yoon JH; Lee HY; Kim BJ; Sung KC; Kang JH; Lee MH; Park JR
    Transl Res; 2006 Oct; 148(4):188-95. PubMed ID: 17002921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of extent of myocardial ischemia in patients with non-ST elevation acute coronary syndrome using serum B-type natriuretic peptide level.
    Choi EY; Kwon HM; Yoon YW; Kim D; Kim HS
    Yonsei Med J; 2004 Apr; 45(2):255-62. PubMed ID: 15118997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease.
    Sahinarslan A; Cengel A; Okyay K; Yazici HU; Elbey S; Cemri M; Ozdemir M; Timurkaynak T
    Coron Artery Dis; 2005 Jun; 16(4):225-9. PubMed ID: 15915074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An elevated level of BNP in plasma is related to the development of good collateral circulation in coronary artery disease.
    Xi WW; Cheng G; Lv S; Gao Q; Bu G; Zhou Y; Xu G
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):797-802. PubMed ID: 21450626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between elevated B-type Natriuretic Peptide levels with extent of coronary artery disease in patients with unstable angina and NSTEMI.
    Romel SM; Faruque M; Bari MA; Bari MS; Aditya GP; Choudhury AK; Khalequzzaman M; Alam MM; Razzaque MA; Rahman MA; Kabir MS; Ahmed KU; Alam MA
    Mymensingh Med J; 2014 Jul; 23(3):544-51. PubMed ID: 25178608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with non-sT-segment elevation myocardial infarction present with more severe systolic and diastolic dysfunction than patients with unstable angina.
    Chaowalit N; Auesethasak R; Santanakorn Y; Jakrapanichakul D; Kittipovanonth M; Chirakarnjanakorn S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S19-24. PubMed ID: 21721424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: relation to coronary artery narrowing and plaques number.
    Palazzuoli A; Rizzello V; Calabrò A; Gallotta M; Martini G; Quatrini I; Campagna MS; Franci B; Nuti R
    Clin Chim Acta; 2008 May; 391(1-2):74-9. PubMed ID: 18328262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction.
    Giallauria F; De Lorenzo A; Pilerci F; Manakos A; Lucci R; Psaroudaki M; D'Agostino M; Del Forno D; Vigorito C
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):625-32. PubMed ID: 16874155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.